Alliances
Janssen Biotech, a Johnson & Johnson company, informed Aduro Biotech that it was terminating its research and license deals related to Aduro’s Listeria treatment for cancers.
Rhinomed signs 12-year exclusive licensing agreement with New York based Columbia Care LLC, the largest and most experienced manufacturer and provider of medical cannabis products and services in the United States.
One-year scheme under ATAA & TADAMON initiatives for financially challenged patients
Dragonfly Therapeutics struck a licensing agreement worth up to $695 million with Merck. Merck will license exclusive rights to Dragonfly’s TriNKET technology platform for a number of solid-tumor programs, the company announced today.
Salix Sales Force to Promote First FDA-Approved Drug for Thrombocytopenia in Chronic Liver Disease Patients Scheduled to Undergo a Procedure
Amyris, Inc. today announced that it has entered into a multi-year, multi-million-dollar agreement with a subsidiary of Yifan Pharmaceutical Co., Ltd.
New collaboration with Coalition for Epidemic Preparedness Innovations (CEPI) and The Jenner Institute is latest example of Johnson & Johnson’s ongoing commitment to global pandemic preparedness efforts
Expedeon AG signs supply agreement with Reszon Diagnostics for proprietary colloidal gold technology
Expedeon’s proprietary colloidal gold to be used for manufacturing of diagnostic lateral flow assays
Accelerates sharing of genomic and health data from more than 150.000 subjects
Collaboration to receive $3.4 million over 5 years from AHRQ and PCORI
PRESS RELEASES